Chugai Pharmaceutical Co., Ltd. (4519) – Financial and Strategic SWOT Analysis Review

Chugai Pharmaceutical Co., Ltd. (4519) – Financial and Strategic SWOT Analysis Review Cover

Single Licence: $125

Buy Now
customer(s) bought this report
BUY WITH CONFIDENCE

Shopping on CFDMaster.com is Safe and Secure. GUARANTEED!
All information is encrypted and handled by PayPal.com

Need Assistance?
Have you got questions about this report? Why not speak to one of our advisors. Email us at business@cfdmaster.com or call us at +61 (02) 8011 3208
# Pages
Market
Country
Single User
Site License
Enterprisewide
52
Pharmaceuticals and Healthcare
Japan

Chugai Pharmaceutical Co., Ltd. (4519) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

– Business description – A detailed description of the company’s operations and business divisions.
– Corporate strategy – Analyst’s summarization of the company’s business strategy.
– SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
– Company history – Progression of key events associated with the company.
– Major products and services – A list of major products, services and brands of the company.
– Key competitors – A list of key competitors to the company.
– Key employees – A list of the key executives of the company.
– Executive biographies – A brief summary of the executives’ employment history.
– Key operational heads – A list of personnel heading key departments/functions.
– Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
– Key manufacturing facilities – A list of key manufacturing facilities of the company.
– Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
– Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Chugai Pharmaceutical Co., Ltd. (Chugai) is a pharmaceutical company with focus on the manufacturing and marketing pharmaceutical products in Japan and other countries. The company’s product portfolio focuses on various therapeutic areas including cancer treatment; bone and joint diseases; renal diseases; immunologic and infectious diseases among others. The company utilizes leading technologies in biopharmaceutical and molecular targeted drug discovery for the development of its drugs and drug candidates.

Chugai Pharmaceutical Co., Ltd. Key Recent Developments

Jan 28, 2015 Chugai Pharmaceutical Announces Consolidated Financial Statements (non-audited) For Fiscal Year 2014
Jan 28, 2015 Chugai to Establish the Organization Specializing in Early Clinical Development
Mar 20, 2014 Chugai to Participate in High-Quality Protein Crystal Growth Experiment
in the International Space Station, “Kibo,” as Private Company

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
– The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
– The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
– Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
– Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
– Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Table of Contents

Section 1 – About the Company 6
Chugai Pharmaceutical Co., Ltd. – Key Facts 6
Chugai Pharmaceutical Co., Ltd. – Key Employees 7
Chugai Pharmaceutical Co., Ltd. – Key Employee Biographies 9
Chugai Pharmaceutical Co., Ltd. – Major Products and Services 10
Chugai Pharmaceutical Co., Ltd. – Pharmaceutical Pipeline Products Data 12
Chugai Pharmaceutical Co., Ltd., Pipeline Products by Therapy Area 12
Chugai Pharmaceutical Co., Ltd., Pipeline Products by Development Phase 13
Chugai Pharmaceutical Co., Ltd. – History 15
Chugai Pharmaceutical Co., Ltd. – Company Statement 23
Chugai Pharmaceutical Co., Ltd. – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Chugai Pharmaceutical Co., Ltd. – Key Manufacturing Facilities 26
Joint Venture 26
Section 2 – Company Analysis 27
Chugai Pharmaceutical Co., Ltd. – Business Description 27
Chugai Pharmaceutical Co., Ltd. – Corporate Strategy 28
Chugai Pharmaceutical Co., Ltd. – SWOT Analysis 29
SWOT Analysis – Overview 29
Chugai Pharmaceutical Co., Ltd. – Strengths 29
Strength – Operational Base 29
Strength – Expansion of Revenue from Cancer Portfolio 29
Strength – Synergy from Roche 29
Chugai Pharmaceutical Co., Ltd. – Weaknesses 30
Weakness – Dependence on Key Customers 30
Weakness – Renal Disease Segment Revenue Hit by NIH Price Revisions 30
Weakness – Cost Control 30
Chugai Pharmaceutical Co., Ltd. – Opportunities 31
Opportunity – HER2-Positive Breast Cancer in Japan 31
Opportunity – Product Approvals and Launches 31
Opportunity – Late Stage Pipeline Portfolio 31
Chugai Pharmaceutical Co., Ltd. – Threats 32
Threat – Intense Competition 32
Threat – Government Regulations 32
Threat – Influx of Generics 32
Chugai Pharmaceutical Co., Ltd. – Key Competitors 33
Section 3 – Company Financial Ratios 34
Financial Ratios – Capital Market Ratios 34
Financial Ratios – Annual Ratios 35
Performance Chart 37
Financial Performance 37
Financial Ratios – Interim Ratios 38
Financial Ratios – Ratio Charts 39
Section 4 – Company’s Lifesciences Financial Deals and Alliances 40
Chugai Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 40
Chugai Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015 41
Chugai Pharmaceutical Co., Ltd., Recent Deals Summary 42
Section 5 – Company’s Recent Developments 43
Jan 28, 2015: Chugai to Establish the Organization Specializing in Early Clinical Development 43
Jan 28, 2015: Chugai Pharmaceutical Announces Consolidated Financial Statements (non-audited) For Fiscal Year 2014 44
Mar 20, 2014: Chugai to Participate in High-Quality Protein Crystal Growth Experiment in the International Space Station, “Kibo,” as Private Company 47
Section 6 – Appendix 48
Methodology 48
Ratio Definitions 48
About GlobalData 52
Contact Us 52
Disclaimer 52



List of Tables
Chugai Pharmaceutical Co., Ltd., Key Facts 6
Chugai Pharmaceutical Co., Ltd., Key Employees 7
Chugai Pharmaceutical Co., Ltd., Key Employee Biographies 9
Chugai Pharmaceutical Co., Ltd., Major Products and Services 10
Chugai Pharmaceutical Co., Ltd., Number of Pipeline Products by Therapy Area 12
Chugai Pharmaceutical Co., Ltd., Number of Pipeline Products by Development Stage 13
Chugai Pharmaceutical Co., Ltd., Pipeline Products By Therapy Area and Development Phase 14
Chugai Pharmaceutical Co., Ltd., History 15
Chugai Pharmaceutical Co., Ltd., Other Locations 24
Chugai Pharmaceutical Co., Ltd., Subsidiaries 24
Chugai Pharmaceutical Co., Ltd., Key Manufacturing Facilities 26
Chugai Pharmaceutical Co., Ltd., Joint Venture 26
Chugai Pharmaceutical Co., Ltd., Key Competitors 33
Chugai Pharmaceutical Co., Ltd., Ratios based on current share price 34
Chugai Pharmaceutical Co., Ltd., Annual Ratios 35
Chugai Pharmaceutical Co., Ltd., Interim Ratios 38
Chugai Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 40
Chugai Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015 41
Chugai Pharmaceutical Co., Ltd., Recent Deals Summary 42
Currency Codes 48
Capital Market Ratios 48
Equity Ratios 49
Profitability Ratios 49
Cost Ratios 50
Liquidity Ratios 50
Leverage Ratios 51
Efficiency Ratios 51



List of Figures
Chugai Pharmaceutical Co., Ltd., Pipeline Products by Therapy Area 12
Chugai Pharmaceutical Co., Ltd., Pipeline Products by Development Phase 13
Chugai Pharmaceutical Co., Ltd., Performance Chart (2010 – 2014) 37
Chugai Pharmaceutical Co., Ltd., Ratio Charts 39
Chugai Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 40
Chugai Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015 41

Report Delivery

PDF SWOT Analysis Report An Electronic PDF copy of this Report will be sent to you via email.

Please allow up to 2 business days for the reports to arrive to your mailbox as some of our publishers prefer to send you the reports directly.

Purchase this Report today

Price: $125

Report Licences Explanation

* Single User: Electronic PDF copy delivered via email. Report can be used by individual purchaser only.

* Site License: Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.

* Enterprise Wide License: Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.

If you require a Site License or Enterprise Wide License please contact us to issue you an invoice.

Customers who Viewed this Report also Viewed

Risk warning: Your capital may be at risk. CFD trading is suitable for experienced traders and not beginners.